Trueblood Wealth Management’s First Trust Emerging Markets AlphaDEX Fund FEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$461K Buy
14,409
+80
+0.6% +$2.59K 0.16% 168
2026
Q1
$429K Buy
14,329
+461
+3% +$13.7K 0.17% 162
2025
Q4
$379K Buy
13,868
+206
+2% +$5.55K 0.15% 176
2025
Q3
$370K Buy
13,662
+496
+4% +$12.9K 0.14% 183
2025
Q2
$323K Sell
13,166
-65
-0.5% -$1.51K 0.14% 193
2025
Q1
$302K Hold
13,231
0.14% 187
2024
Q4
$291K Sell
13,231
-586
-4% -$13.4K 0.14% 186
2024
Q3
$331K Buy
13,817
+2,100
+18% +$49.1K 0.17% 166
2024
Q2
$281K Hold
11,717
0.16% 171
2024
Q1
$268K Sell
11,717
-3,343
-22% -$75.7K 0.15% 174
2023
Q4
$333K Buy
+15,060
New +$315K 0.21% 138

Other funds holding FEM

Trueblood Wealth Management's FEM Position: Q2 2026 in Review

Trueblood Wealth Management increased its First Trust Emerging Markets AlphaDEX Fund (FEM) stake by 0.56% in Q2 2026, buying an estimated $2.59K and bringing the position to 14,409 shares worth $461K. The position accounts for 0.16% of the portfolio, ranked #168.

Trueblood Wealth Management first reported a position in FEM in Q4 2023 and has held it in 11 quarters since. 153 funds tracked by Wall St. Rank hold FEM as of Q2 2026.

  • Trueblood Wealth Management held 14,409 shares of First Trust Emerging Markets AlphaDEX Fund worth $461K as of Q2 2026.
  • Trueblood Wealth Management bought 80 First Trust Emerging Markets AlphaDEX Fund shares in Q2 2026, an estimated $2.59K.
  • First Trust Emerging Markets AlphaDEX Fund made up 0.16% of Trueblood Wealth Management's portfolio in Q2 2026, its #168 holding.
  • Trueblood Wealth Management first reported a position in First Trust Emerging Markets AlphaDEX Fund in Q4 2023 and has held it in 11 quarters since.
  • 153 funds tracked by Wall St. Rank held First Trust Emerging Markets AlphaDEX Fund as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.